JP Patent

JP5937112B2 — 選択的ｆａｋ阻害剤

Assigned to Cancer Therapeutics CRC Pty Ltd · Expires 2016-06-22 · 10y expired

What this patent protects

Patent listed against Zykadia.

Drugs covered by this patent

Zykadia (ceritinib) · Novartis

Patent Metadata

Patent number: JP5937112B2
Jurisdiction: JP
Classification: —
Expires: 2016-06-22
Drug substance claim: No
Drug product claim: No
Assignee: Cancer Therapeutics CRC Pty Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.